Jianjun Cheng

Q: What Schools Are Affiliated With Jianjun Cheng

Jianjun Cheng is affiliated with the following schools: University of California, Berkeley, University of Science and Technology of China, University of Illinois Urbana-Champaign, ShanghaiTech University, University of Illinois Chicago

Jianjun Cheng's AcademicInfluence.com Rankings

Jianjun Cheng

Engineering

#8179

World Rank

#9669

Historical Rank

Materials Science

#537

World Rank

#546

Historical Rank

Applied Physics

#3638

World Rank

#3761

Historical Rank

engineering Degrees

Download Badge

Engineering

Jianjun Cheng's Degrees

PhD Polymer Chemistry and Physics University of Science and Technology of China
Bachelors Polymer Science and Engineering University of Science and Technology of China

Why Is Jianjun Cheng Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Jianjun Cheng is a Chinese material scientist. Early life and education Cheng completed his Bachelor of Science degree at Nankai University in 1993 before moving to North America for his graduate studies. In 1996, he completed his master's degree at Southern Illinois University Carbondale and later earned his PhD in Materials Science at the University of California, Santa Barbara.

(See a Problem?)

Jianjun Cheng's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

5-HT2C Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology (2018) (160)
G protein-coupled receptors: structure- and function-based drug discovery (2021) (110)
Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential. (2018) (77)
Haloperidol bound D2 dopamine receptor structure inspired the discovery of subtype selective ligands (2020) (56)
Structure-based discovery of nonhallucinogenic psychedelic analogs (2022) (45)
5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in Mice (2017) (36)
Momilactone and Related Diterpenoids as Potential Agricultural Chemicals. (2018) (29)
Optimization of 2-phenylcyclopropylmethylamines as selective serotonin 2C receptor agonists and their evaluation as potential antipsychotic agents. (2015) (26)
Design and Discovery of Functionally Selective Serotonin 2C (5-HT2C) Receptor Agonists. (2016) (24)
Optimization of P2Y12 Antagonist Ethyl 6-(4-((Benzylsulfonyl)carbamoyl)piperidin-1-yl)-5-cyano-2-methylnicotinate (AZD1283) Led to the Discovery of an Oral Antiplatelet Agent with Improved Druglike Properties. (2019) (22)
Further Advances in Optimizing (2-Phenylcyclopropyl)methylamines as Novel Serotonin 2C Agonists: Effects on Hyperlocomotion, Prepulse Inhibition, and Cognition Models. (2016) (20)
Enhancing the Signaling of GPCRs via Orthosteric Ions (2020) (19)
We Need 2C but Not 2B: Developing Serotonin 2C (5‐HT2C) Receptor Agonists for the Treatment of CNS Disorders (2015) (18)
Identification of natural products as novel ligands for the human 5-HT2C receptor (2018) (18)
Tumor Immunotherapy Using A2A Adenosine Receptor Antagonists (2020) (17)
Discovery of N-Substituted (2-Phenylcyclopropyl)methylamines as Functionally Selective Serotonin 2C Receptor Agonists for Potential Use as Antipsychotic Medications. (2017) (15)
Structure-based design of a novel third-generation antipsychotic drug lead with potential antidepressant properties (2021) (12)
Design and Synthesis of (2-(5-Chloro-2,2-dimethyl-2,3-dihydrobenzofuran-7-yl)cyclopropyl)methanamine as a Selective Serotonin 2C Agonist. (2015) (12)
Design and Synthesis of Bitopic 2-Phenylcyclopropylmethylamine (PCPMA) Derivatives as Selective Dopamine D3 Receptor Ligands. (2020) (9)
Long Residence Time at the Vasopressin V2 Receptor Translates into Superior Inhibitory Effects in Ex Vivo and In Vivo Models of Autosomal Dominant Polycystic Kidney Disease. (2022) (6)
The unconventional activation of the muscarinic acetylcholine receptor M4R by diverse ligands (2022) (6)
Structure-Based Design of Dual-Acting Compounds Targeting Adenosine A2A Receptor and Histone Deacetylase as Novel Tumor Immunotherapeutic Agents. (2021) (5)
Revisit ligand-receptor interaction at the human vasopressin V2 receptor: A kinetic perspective. (2020) (5)
Structural basis for strychnine activation of human bitter taste receptor TAS2R46 (2022) (5)
2-Phenylcyclopropylmethylamine Derivatives as Dopamine D2 Receptor Partial Agonists: Design, Synthesis, and Biological Evaluation. (2021) (4)
Dual-acting antitumor agents targeting the A2A adenosine receptor and histone deacetylases: Design and synthesis of 4-(furan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-amine derivatives. (2022) (2)
Design of fluorinated cyclopropane derivatives of 2-phenylcyclopropylmethylamine leading to identification of a selective serotonin 2C (5-HT2C) receptor agonist without 5-HT2B agonism. (2019) (2)
MULTISCALE COMPLEXITY OF CALCIUM SIGNALING : MODELING ANGIOGENESIS (1)
Design and Synthesis of Triazole-Containing HDAC Inhibitors That Induce Antitumor Effects and Immune Response. (2023) (0)
Crystal structure of 5-HT2C in complex with ergotamine (2018) (0)
Structural basis of G protein couple receptor polypharmacology (2018) (0)
Crystal structure of 5-HT2C in complex with ritanserin (2018) (0)
Scaffold repurposing of a serotonin 2C agonist led to the discovery of highly selective dopamine D3 antagonists (2019) (0)
Further Advances in Optimizing (2-Phenylcyclopropyl)methylamines as Novel Serotonin 2C Agonists: Effects in Open Field, Prepulse Inhibition, and Cognition Models (2021) (0)
Dual-acting compounds targeting the adenosine 2A receptor (A2AR) and histone deacetylases (HDACs) for cancer immunotherapy (2019) (0)
Pheromone Receptors Help Cnaphalocrocis medinalis Avoid Competition in Rice Fields (2021) (0)
Design and synthesis of tri-substituted pyrimidine derivatives as bifunctional tumor immunotherapeutic agents targeting both A2A adenosine receptors and histone deacetylases (2023) (0)
Structure-based design of a novel third-generation antipsychotic drug lead with potential antidepressant properties (2021) (0)
Carbon-silicon switch led to the discovery of novel synthetic cannabinoids with therapeutic effects in a mouse model of multiple sclerosis. (2021) (0)
Biochemical analysis of the interactions of IQGAP 1 C-terminal domain with CDC 42 (2012) (0)
Transformation of a Dopamine D2 Receptor Agonist to Partial Agonists as Novel Antipsychotic Agents. (2023) (0)
Azide-Masked Resiquimod Activated by Hypoxia for Selective Tumor Therapy. (2023) (0)
Optical-Controlled Kinetic Switch: Fine-Tuning of the Residence Time of an Antagonist Binding to the Vasopressin V2 Receptor in In Vitro, Ex Vivo, and In Vivo Models of ADPKD. (2022) (0)

This paper list is powered by the following services:

Other Resources About Jianjun Cheng

en.wikipedia.org

What Schools Are Affiliated With Jianjun Cheng?

Jianjun Cheng is affiliated with the following schools:

Jianjun Cheng's Academic­Influence.com Rankings

Jianjun Cheng's Degrees

Why Is Jianjun Cheng Influential?

Jianjun Cheng's Published Works

Published Works

Other Resources About Jianjun Cheng

What Schools Are Affiliated With Jianjun Cheng?

Jianjun Cheng's AcademicInfluence.com Rankings